Supernus Pharmaceuticals Stock Price. Everything You Need To Know About The Supernus Pharmaceuticals Stock!
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. The company is headquartered in Rockville, Maryland and currently employs 612 full-time employees. The company went IPO on 2010-12-28. The firm is focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The firm’s diverse neuroscience portfolio includes treatments for epilepsy, migraine, attention deficit hyperactivity disorder (ADHD), hypomobility in Parkinson’s disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company is also developing a range of CNS product candidates, including potential treatments for hypomobility in PD, epilepsy, depression, and other CNS disorders. Its commercial portfolio of products includes Trokendi XR (topiramate) and Oxtellar XR (oxcarbazepine) for the treatment of epilepsy. Its APOKYN (apomorphine hydrochloride injection) is a product indicated for the acute, intermittent treatment of hypomobility in patients with advanced Parkinson’s disease (PD).
Supernus Pharmaceuticals Stock Price. Everything You Need To Know About The Supernus Pharmaceuticals Stock! performance
- Employees 612
- Company HQ Rockville
- Website https://www.supernus.com
- SUPN Asset Type Common Stock
- SUPN Market Capitalization 1.6B
- Earnings Per Share 0.02
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth -0.959
Are you looking to invest in the stock market from Malaysia, Thailand, Indonesia, or Vietnam? Supernus Pharmaceuticals should be on your radar. As a leading content marketing expert at Zorion, we recommend considering Supernus Pharmaceuticals as a potential investment opportunity. With Zorion’s investment insights and recommendations, retail investors like you can make well-informed decisions about your investment portfolio. Supernus Pharmaceuticals, a well-established pharmaceutical company, specializes in developing and commercializing innovative treatments for central nervous system diseases. With Zorion’s resources and educational materials, you can further enhance your investment knowledge and confidently invest in Supernus Pharmaceuticals. Take advantage of this opportunity and explore the potential of Supernus Pharmaceuticals in the stock market today!
